Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to 0.09.

  • Fennec Pharmaceuticals' Equity Ratio fell 390.4% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 390.4%. This contributed to the annual value of 0.13 for FY2024, which is 6980.15% up from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Equity Ratio stood at 0.09 for Q3 2025, which was down 390.4% from 0.17 recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Equity Ratio high stood at 0.9 for Q1 2021, and its period low was 0.5 during Q2 2023.
  • Over the past 5 years, Fennec Pharmaceuticals' median Equity Ratio value was 0.05 (recorded in 2024), while the average stood at 0.12.
  • In the last 5 years, Fennec Pharmaceuticals' Equity Ratio soared by 42060.35% in 2023 and then plummeted by 67404.9% in 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Equity Ratio (Quarter) stood at 0.73 in 2021, then crashed by 113.05% to 0.1 in 2022, then tumbled by 353.66% to 0.43 in 2023, then surged by 69.8% to 0.13 in 2024, then skyrocketed by 30.2% to 0.09 in 2025.
  • Its last three reported values are 0.09 in Q3 2025, 0.17 for Q2 2025, and 0.13 during Q1 2025.